Abingdon Health Plc
ABDXF · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Revenue | $6,135 | $4,045 | $2,835 | $11,618 |
| % Growth | 51.7% | 42.7% | -75.6% | – |
| Cost of Goods Sold | $2,456 | $1,970 | $8,064 | $8,224 |
| Gross Profit | $3,679 | $2,075 | -$5,229 | $3,394 |
| % Margin | 60% | 51.3% | -184.4% | 29.2% |
| R&D Expenses | $0 | $0 | $182 | $503 |
| G&A Expenses | $5,070 | $5,220 | $6,645 | $7,547 |
| SG&A Expenses | $5,070 | $5,248 | $6,694 | $8,411 |
| Sales & Mktg Exp. | $0 | $28 | $49 | $864 |
| Other Operating Expenses | -$18 | $443 | $0 | $0 |
| Operating Expenses | $5,052 | $5,248 | $6,876 | $8,914 |
| Operating Income | -$1,373 | -$3,588 | -$12,105 | -$5,520 |
| % Margin | -22.4% | -88.7% | -427% | -47.5% |
| Other Income/Exp. Net | -$26 | $14 | -$65 | -$234 |
| Pre-Tax Income | -$1,399 | -$3,574 | -$21,685 | -$7,054 |
| Tax Expense | -$128 | -$105 | -$423 | -$81 |
| Net Income | -$1,271 | -$3,469 | -$21,262 | -$6,973 |
| % Margin | -20.7% | -85.8% | -750% | -60% |
| EPS | -0.004 | -0.011 | -0.073 | -0.073 |
| % Growth | 63.2% | 84.4% | -0.4% | – |
| EPS Diluted | -0.004 | -0.011 | -0.073 | -0.073 |
| Weighted Avg Shares Out | 302,619 | 304,033 | 291,623 | 95,984 |
| Weighted Avg Shares Out Dil | 304,732 | 304,033 | 291,623 | 95,984 |
| Supplemental Information | – | – | – | – |
| Interest Income | $31 | $89 | $4 | $0 |
| Interest Expense | $57 | $75 | $69 | $234 |
| Depreciation & Amortization | $426 | $774 | $759 | $8,829 |
| EBITDA | -$916 | -$3,173 | -$19,887 | -$4,771 |
| % Margin | -14.9% | -78.4% | -701.5% | -41.1% |